Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Neovii has signed a research and license agreement with Tel Aviv University to develop a novel COVID-19 vaccine.
read more
During COVID-19, FDA will continue to utilize and implement additional alternative inspection tools and approaches while postponing domestic and foreign routine surveillance inspections.
read more
CiRA Foundation and the CGT Catapult are launching a new collaborative research project focused on induced pluripotent stem cell characterization.
read more
Skyhawk Therapeutics has expanded its strategic collaboration with Merck to discover, develop, and commercialize small molecules that modulate RNA splicing.
read more
Sterling Pharma Solutions has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Fresenius Medical Care North America's Renal Therapies Group is preparing its first shipment of multiBic dialysate solutions for use in continuous renal replacement therapy.
read more
Mylan announced a global collaboration with Gilead Sciences to expand access to the investigational antiviral remdesivir for the potential treatment of COVID-19.
read more
Parexel unveiled its COVID-19 Risk Mitigation offering, which leverages the company’s experience with global viral outbreaks as well as cGMP inspection and CMC review processes to ensure that manufacturers can safely and confidently continue ...
read more
U.S. Pharmacopeia (USP) has launched a new program to support scientists, developers and manufacturers worldwide.
read more
MasterPharm is voluntarily recalling 1 lot of Finasteride Plus 1.25mg, capsules to the consumer level.
read more
QPS has announced a newly developed capability to conduct COVID-19 testing, available as of May 11, 2020.
read more
Parexel has unveiled its COVID-19 Risk Mitigation offering, which leverages the company’s experience with global viral outbreaks.
read more
Fluxergy is making a $30 million investment to expand its capability to scale production of the Fluxergy Analyzer diagnostic testing system in response to the COVID-19 pandemic.
read more
Sabin announced BARDA has exercised the first two options, valued at $20 million advance the development of vaccines against Ebola Sudan and Marburg viruses through Phase 2 clinical trials.
read more